|

From target to therapeutic: Early PK considerations in antimicrobial drug development (Keynote)

5
Sep

From target to therapeutic: Early PK considerations in antimicrobial drug development (Keynote)

Alex Lepak (U of Wisconsin)
ajlepak@medicine.wisc.edu

About Post Author

cibanez3's avatar

Leave a Reply

About Us

The Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) is a joint conference organized by ASM and the Infectious Diseases Society of America (IDSA).